Celldex Therapeutics, Inc. (CLDX) market cap

Market cap today
$2.20B

Celldex Therapeutics, Inc. (CLDX) has a market cap of $2.20B. At the end of fiscal 2025 (December 31, 2025) its market cap was $1.80B. That is 10.9% higher than the $1.63B of fiscal 2024. Today's figure is 22.1% above the fiscal 2025 year-end. Figures as of 18 Nov 2026, 05:00 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$2.20B
Market cap, fiscal 2025
$1.80B
Change on fiscal 2024
+10.9%
Growth, 5 years
+410.7% a year
Highest on record
$2.09Bfiscal 2022
Lowest on record
$32.35Kfiscal 2019
Fiscal years on record
102009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Celldex Therapeutics, Inc. market cap, in more detail

Over the five fiscal years to 2025 the market cap grew at a compound 410.7% a year. Across the 10 fiscal year-ends on record (2009–2025), the highest was $2.09B in fiscal 2022 and the lowest $32.35K in fiscal 2019.

History · 10 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Celldex Therapeutics, Inc. market cap, year by year

Celldex Therapeutics, Inc. (CLDX) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$2.20B—$28.04—
2025$1.80B 10.9% up$27.1666.42M
2024$1.63B 15.3% down$25.2764.40M
2023$1.92B 8.1% down$39.6648.45M
2022$2.09B 126,057.7% up$44.5746.89M
2021$1.66M 219.0% up$38.6442.87K
2020$519.29K 1,505.2% up$17.5229.64K
2019$32.35K—$2.2314.51K
2018——$3.00—
2017——$42.60—
2016——$53.10—
2015——$235.20—
2014——$273.75—
2013——$363.15—
2012——$100.65—
2011$102.70M 21.8% down$39.002.63M
2010$131.30M 41.8% up$61.802.12M
2009$92.57M—$70.051.32M

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

More on CLDX

Celldex Therapeutics, Inc., figure by figure

Celldex Therapeutics, Inc. (CLDX) overview: price, valuation and scorecard

Celldex Therapeutics, Inc. market cap: questions and answers

What is Celldex Therapeutics, Inc.'s market cap?

Celldex Therapeutics, Inc. (CLDX) has a market cap of $2.20B. At the end of fiscal 2025 (December 31, 2025) its market cap was $1.80B. That is 10.9% higher than the $1.63B of fiscal 2024.

What is the growth rate of Celldex Therapeutics, Inc.'s market cap?

Over the five fiscal years to 2025 the market cap grew at a compound 410.7% a year.

What are the highest and lowest market cap figures on record for Celldex Therapeutics, Inc.?

Across the 10 fiscal year-ends on record (2009–2025), the highest was $2.09B in fiscal 2022 and the lowest $32.35K in fiscal 2019.

How is Celldex Therapeutics, Inc.'s market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Celldex Therapeutics, Inc. (CLDX) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/CLDX/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.